Nursing Care for the Patient with Cavernous Sinus Thrombosis and Mucormycosis: A Case Report Based on Gordon's Functional Health Patterns Model

Year 2025, Volume: 6 Issue: 2, 149 - 167, 01.10.2025

Ferhat Koç , Merve Gülbahar Eren , Havva Sert

https://doi.org/10.70479/thdd.1653377

Abstract

Purpose: This study aimed to provide an evidence-based nursing care plan from the perspective of Gordon’s Functional Health Patterns Model for a patient diagnosed with cavernous sinus thrombosis and mucormycosis in the intensive care unit.
Methods: This was a case report study examining nursing care plans in accordance with the NANDA nursing diagnoses, nursing outcomes classification, and nursing interventions classification.
Findings: A 41-year-old female patient with visual impairment was admitted to the hospital. In the later stages of the treatment, further investigations were performed by suspecting the necrotic tissues in orbit, and a diagnosis of rhinocerebral mucormycosis was determined. The patient, treated in the intensive care unit for 37 days, was evaluated in 11 functional areas in the Functional Health Patterns Model. Nursing diagnoses were acute pain, hyperthermia, impaired oral mucous membrane integrity, ineffective breathing pattern, risk for infection, risk for impaired skin integrity, imbalanced nutrition, ineffective health self-management, risk for unstable blood glucose level.
Conclusion: The Functional Health Patterns Model can be utilized as a valuable and effective model in assessing the patient with a diagnosis of mucormycosis in the intensive care unit with a holistic and systematic perspective and in providing professional nursing care.
Implications for nursing practices: Providing care based on the nursing model is crucial, especially in rare diseases. Holistic evaluation of the patient, meeting his acute needs, and evaluating nursing interventions based on evidence can improve patient outcomes. This case report can provide insight into further research to overlook the assessment of the patients treated with the diagnosis of CST in terms of mucormycosis, to be aware of the prevalence of this disease, and to acquire information about the prevention, early diagnosis, and maintenance of the disease.

Keywords

mucormycosis , case report , nursing care , kavernöz sinüs tromboz

Ethical Statement

This study was conducted in accordance with the principles of the Declaration of Helsinki. The confidentiality of patient information presented in the case report has been maintained, and no identifiable data has been shared. Informed consent was obtained from the patient or their legal representative, and the study does not contain any ethical violations.

Thanks

We would like to thank Prof. Dr. Bilgehan Atılgan ACAR and Dr. Alper ERYILMAZ for their contributions to the study.

Kavernöz Sinüs Trombozu ve Mukormikozlu Hastada Hemşirelik Bakımı: Gordon'un Fonksiyonel Sağlık Örüntüleri Modeline Dayalı Bir Olgu Sunumu

Abstract

Amaç: Bu çalışma, yoğun bakım ünitesinde kavernöz sinüs trombozu ve mukormikoz tanısı almış bir hastaya yönelik olarak, Gordon’un Fonksiyonel Sağlık Örüntüleri Modeli perspektifinden kanıta dayalı bir hemşirelik bakım planı sunmayı amaçlamaktadır.

Yöntem: Bu çalışma, NANDA hemşirelik tanıları, hemşirelik sonuç sınıflandırması (NOC) ve hemşirelik girişimleri sınıflandırması (NIC) doğrultusunda hemşirelik bakım planlarını inceleyen bir olgu sunumu çalışmasıdır.

Bulgular: Görme kaybı bulunan 41 yaşında bir kadın hasta hastaneye kabul edilmiştir. Tedavinin ileri aşamalarında orbital bölgede nekrotik doku şüphesi nedeniyle ileri tetkikler yapılmış ve hastaya rinosebral mukormikoz tanısı konulmuştur. Yoğun bakım ünitesinde 37 gün boyunca tedavi edilen hasta, Fonksiyonel Sağlık Örüntüleri Modeli kapsamında 11 fonksiyonel alanda değerlendirilmiştir. Belirlenen hemşirelik tanıları arasında akut ağrı, hipertermi, bozulmuş oral mukozal bütünlük, etkisiz solunum örüntüsü, enfeksiyon riski, bozulmuş deri bütünlüğü riski, dengesiz beslenme, etkisiz sağlık öz yönetimi ve dengesiz kan glukoz düzeyi riski yer almaktadır.

Sonuç: Fonksiyonel Sağlık Örüntüleri Modeli, yoğun bakım ünitesinde mukormikoz tanısı almış hastaların bütüncül ve sistematik bir yaklaşımla değerlendirilmesinde ve profesyonel hemşirelik bakımının sağlanmasında değerli ve etkili bir model olarak kullanılabilir.

Hemşirelik uygulamaları için çıkarımlar: Özellikle nadir hastalıklarda hemşirelik modeline dayalı bakım sunmak büyük önem taşımaktadır. Hastanın bütüncül değerlendirilmesi, akut ihtiyaçlarının karşılanması ve hemşirelik girişimlerinin kanıta dayalı olarak değerlendirilmesi hasta sonuçlarını iyileştirebilir. Bu olgu sunumu, kavernöz sinüs trombozu (CST) tanısı almış hastaların mukormikoz açısından değerlendirilmesi, bu hastalığın yaygınlığı hakkında farkındalık oluşturulması, önleme, erken tanı ve hastalığın yönetimi konusunda bilgi edinilmesi açısından gelecekte yapılacak araştırmalara ışık tutabilir.

Keywords

mukormikoz , hemşirelik bakımı , kavernöz sinüs trombozu , vaka raporu

References

• 1 Aggarwal S.K. Invasive sino-orbito-cerebral mycosis–An overview. Indian J Clin Exp Ophthamol 2015;1:149.
• 2. Pathak V.K., Tyagi S, Nehra A, Yadav L. Rhino-Orbital Cerebral Mucormycosis with Cavernous Sinus Thrombosis with Ophthalmoplegia. Journal of Dental and Medical Sciences, 2019;18(7):50–3.
• 3 Prakash Hariprasath, Chakrabarti Arunaloke. Global Epidemiology of Mucormycosis. J Fungi (Basel) 2019;5(1), Doi: 10.3390/jof5010026.
• 4 Jeong W, Keighley C, Wolfe R, Lee W. L, Slavin M, Slavin M, et al. The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports. Clinical Microbiology and Infection 2019;25(1):26–34.
• 5 Geng B, Wu X, Malhotra A. Septic cavernous sinus thrombosis—Case series and review of the literature. Clin Neurol Neurosurg 2020:197.
• 6 Caranfa J.T., Yoon M.K. Septic cavernous sinus thrombosis: a review. Surv Ophthalmol 2021;66(6):1021–30.
• 7 Mira Filipe, Costa Bruno, Paiva Catarina, Andrês Rui, Loureiro António. Cavernous Sinus Thrombosis. Rev Bras Oftalmol 2023;73(3):182–4, Doi: 10.5935/0034-7280.20140040.
• 8 Türen Sevda, Enç Nuray. A comparison of Gordon’s functional health patterns model and standard nursing care in symptomatic heart failure patients: A randomized controlled trial. Applied Nursing Research 2020;53:151247, Doi: 10.1016/j.apnr.2020.151247.
• 9 Gengo e Silva Butcher Rita de Cassia, Jones Dorothy A. An integrative review of comprehensive nursing assessment tools developed based on Gordon’s Eleven Functional Health Patterns. Int J Nurs Knowl 2021;32(4):294–307, Doi: 10.1111/2047-3095.12321.
• 10 Davarpanah Iman, Adine Mohamad, Elahi Nasrin, Haghighizadeh Mohammad Hosein, Javaherforooshzadeh Fatemeh. The Effect of Implementing Nursing Care Based on Gordon’s Model on the Clinical Outcomes of Patients Undergoing Coronary Artery Bypass Surgery: A Quasi-experimental Study. Jundishapur Journal of Chronic Disease Care 2023;13(2), Doi: 10.5812/jjcdc-139899.
• 11 Gagnier Joel J., Kienle Gunver, Altman Douglas G., Moher David, Sox Harold, Riley David, et al. The CARE guidelines: consensus-based clinical case reporting guideline development. Glob Adv Health Med 2013;2(5):3501554–43, Doi: 10.1136/BCR-2013-201554.
• 12 Jacobs P, Wood L, Esterhuizen K. Eradication of invasive mucormycosis-effectiveness of the echinocandin FK463. Hematology 2003;8(2):119–23.
• 13 Ito H, Kakizaki R, Harada K, Kyuno D, Kubo T, Bunya N, et al. . Disseminated mucormycosis in a patient with severe COVID-19 on venovenous extracorporeal membrane oxygenation. Int J Surg Case Rep 2022;96.
• 14 Bellazreg F., Hattab Z., Meksi S., Mansouri S., Hachfi W., Kaabia N., et al. Erratum to, ‘Outcome of mucormycosis after treatment: report of five cases’ . New Microbe and New Infect 2016;11:28–31.
• 15 Bunevicius A, Peceliuniene J, Mickuviene N, Valius L, Bunevicius R. Screening for depression and anxiety disorders in primary care patients. . Depress Anxiety 2007;24:455–60.
• 16 Niti M., Kua E.H., Ho R.C., Tan C.H. Depression and chronic medical illnesses in Asian older adults: the role of subjective health and functional status. Int J Geriatr Psychiatry 2007;22:1087–94.
• 17 Goel A, Shenoy A, Shah A, Goel N, Vutha R, Hawaldar A. Cavernous Hemangioma of Cavernous Sinus: An Outcome Report of 45 Surgically Treated Patients . World Neurosurg 2022;159:381–9.
• 18 Skiada A, Pagano L, Groll A, Zimmerli S, Dupont B, Lagrou K. Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clin Microbiol Infect 2011;17:1859–67.
• 19 Gupta K. L., Radotra B. D., Sakhuja V., Banerjee A. K., Chugh K. S. Mucormycosis in Patients with Renal Failure. . Renal Failure 1989;4(11):195–9.
• 20 Sugar A. Agents of mucormycosis and related species. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases.6th ed. Philadelphia: Elsevier; 2005. p. 2979.
• 21 Chamilos G, Lewis R.E., Kontoyiannis D.P. Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. Clin Infect Dis 2008;47(4):503–9.
• 22 Ener B. Mukormikoz etkenleri. In: Topçu AW, Söyletir G, Doğanay M, editors. İnfeksiyon Hastalıkları ve Mikrobiyolojisi. İstanbul: Nobel Tıp Kitabevleri; 2002. p. 1828–33.
• 23 Mondy K.E., Haughey B., Custer P.L. Rhinocerebral mucormycosis in the era of lipid-based amphotericin B: case report and literature review, . Pharmacotherapy 2002;22(4):519–26.